Regulatory PathRegulatory requirements compared

Active substance

Fluocinonide

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
FLUOCINONIDE0.05%cream · topicalSUN PHARMA CANADAPrescription10 Jun 1987
FLUOCINONIDE EMULSIFIED BASE0.05%cream · topicalTAROPrescription19 Jan 1989
FLUOCINONIDE0.05%cream · topicalTEVAPrescription6 Feb 1989
FLUOCINONIDE EMULSIFIED BASE0.05%cream · topicalTEVAPrescription7 Feb 1989
FLUOCINONIDE0.05%ointment · topicalTEVAPrescription27 Dec 1991
FLUOCINONIDE0.05%cream · topicalCOSETTE PHARMS NCPrescription14 Feb 1992
FLUOCINONIDE0.05%cream · topicalFOUGERA PHARMS INCPrescription17 Oct 1994
FLUOCINONIDE0.05%gel · topicalFOUGERA PHARMS INCPrescription30 Dec 1994
FLUOCINONIDE0.05%solution · topicalFOUGERA PHARMS INCPrescription27 Feb 1995
FLUOCINONIDE EMULSIFIED BASE0.05%cream · topicalCOSETTE PHARMS NCPrescription13 Jun 1995
FLUOCINONIDE0.05%solution · topicalSUN PHARMA CANADAPrescription31 Dec 1996
FLUOCINONIDE0.05%gel · topicalSUN PHARMA CANADAPrescription29 Jul 1997
FLUOCINONIDE0.05%ointment · topicalFOUGERA PHARMSPrescription26 Aug 1997
FLUOCINONIDE0.05%ointment · topicalSUN PHARMA CANADAPrescription30 Jun 1999
FLUOCINONIDE EMULSIFIED BASE0.05%cream · topicalFOUGERA PHARMSPrescription23 Jun 2004
VANOS0.1%cream · topicalBAUSCHPrescription11 Feb 2005
FLUOCINONIDE0.1%cream · topicalSUN PHARMA CANADAPrescription14 Jul 2014
FLUOCINONIDE0.1%cream · topicalFOUGERA PHARMS INCPrescription14 Jul 2014
FLUOCINONIDE0.05%solution · topicalNOVEL LABS INCPrescription21 Jul 2017
FLUOCINONIDE0.05%ointment · topicalCHARTWELL RXPrescription31 Jul 2017
FLUOCINONIDE0.05%solution · topicalCHARTWELL RXPrescription23 Apr 2018
FLUOCINONIDE0.05%solution · topicalMACLEODS PHARMSPrescription23 Apr 2018
FLUOCINONIDE0.05%gel · topicalPADAGIS USPrescription19 Jun 2018
FLUOCINONIDE0.05%solution · topicalZYDUS PHARMSPrescription17 Jul 2018
FLUOCINONIDE0.05%cream · topicalAMNEALPrescription21 Aug 2018

23 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
LYDERM007168630.05 % / W/WCREAM · TOPICALTAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
LYDERM022369960.05 %OINTMENT · TOPICALTAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
LYDERM022369970.05 %GEL · TOPICALTAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
TIAMOL CREAM 0.05%005989330.05 %CREAM · TOPICALTAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACFLUOCINONIDE 0.05% CREAM$0.36656per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% CREAM$0.24322per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% CREAM$0.21715per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% CREAM$0.47223per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% GEL$1.08419per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% GEL$1.02121per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% GEL$0.60044per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% OINTMENT$0.36848per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% OINTMENT$0.25638per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% OINTMENT$0.2058per GM23 Sep 2026
US NADACFLUOCINONIDE 0.05% SOLUTION$0.20487per ML23 Sep 2026
US NADACFLUOCINONIDE 0.05% SOLUTION$0.31434per ML23 Sep 2026
NHS Drug TariffFluocinonide 0.05% cream£3.9625 gram1 Oct 2026
NHS Drug TariffFluocinonide 0.05% cream£13.34100 gram1 Oct 2026
NHS Drug TariffFluocinonide 0.05% ointment£13.15100 gram1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.